Page 93 - Abt News Today

Apricus wealth LLC bought a new stake in Abbott Laboratories (NYSE:ABT – Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 1,924 shares of the healthcare product maker’s stock, valued at approximately $206,000. A number of other hedge funds have also modified […]

Veracity Capital LLC increased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 7.1% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,570 shares of the healthcare product maker’s stock after purchasing an additional 301 shares during the quarter. Veracity Capital LLC’s holdings […]

Osborne Partners Capital Management LLC raised its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 0.9% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 111,012 shares of the healthcare product maker’s stock after buying an additional 1,040 shares during the quarter. Osborne […]

Tower Bridge Advisors decreased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 30.5% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 42,134 shares of the healthcare product maker’s stock after selling 18,471 shares during the period. Tower Bridge Advisors’ holdings in Abbott […]

Beacon Financial Group reduced its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 4.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,045 shares of the healthcare product maker’s stock after selling 489 shares during the […]

Coerente Capital Management cut its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 0.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 227,192 shares of the healthcare product maker’s stock after selling 405 shares during the period. Abbott Laboratories makes up […]

Coerente Capital Management trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 0.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 227,192 shares of the healthcare product maker’s stock after selling 405 shares during the quarter. Abbott Laboratories accounts for 5.3% […]

Duncker Streett & Co. Inc. trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,359 shares of the healthcare product maker’s stock after selling 122 […]

Beacon Financial Group decreased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 4.6% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,045 shares of the healthcare product maker’s stock after selling 489 shares during the period. Beacon […]

Tower Bridge Advisors cut its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 30.5% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 42,134 shares of the healthcare product maker’s stock after selling 18,471 shares during the quarter. Tower Bridge Advisors’ holdings in Abbott Laboratories were […]